Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2013; 19(46): 8543-8551
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8543
Table 1 Previous representative studies of colonic surgery with early rehabilitation programs
Ref.CountryStudy designInclusion periodPatients (n)OperationsApproachLOS (d)
Readmissions
MorbidityMortality
ERPCCERPCCERPCCERPCC
Anderson et al[3], 2003United KingdomRCTND25 (ERP: 14, CC: 11)Cancer: 18 (72)ERP: 11, CC: 7RH: 14 (ERP: 9, CC: 5)LH: 11 (ERP: 5, CC: 6)ND3 (2-7)7 (4-10)a0 (0)0 (0)4 (29)5 (45)0 (0)1 (9)
Gatt et al[4], 2005United KingdomRCTND39 (ERP: 19, CC: 20)Cancer: 27 (69)ERP: 12, CC: 15RH: 10 (ERP: 5, CC: 5)AR: 15 (ERP: 5, CC: 10)Others: 14 (ERP: 9, CC: 5)ND5 (4-9)7.5 (6-10)a1 (5)4 (20)9 (47)15 (75)1 (5)0 (0)
Khoo et al[5], 2007United KingdomRCT2003-200470 (ERP: 35, CC: 35)Cancer: 70 (100)Colonic: 47 (ERP: 22, CC: 25)Rectal: 23 (ERP: 13, CC: 10)Open5 (3-37)7 (4-63)a3 (9)1 (3)9 (26)16 (46)0 (0)2 (6)
Muller et al[6], 2009SwitzerlandRCT2004-2006151 (ERP: 76, CC: 75)Cancer: 131 (87)ERP: 67, CC: 64RH: 48 (ERP: 26, CC: 22)AR/LH: 101(ERP: 30, CC: 51)Open5 (2-30)9 (6-30)a3 (4)2 (3)16 (21)37 (49)a0 (0)0 (0)
Serclova et al[7], 2009CzechRCT2005-2007103 (ERP: 51, CC: 52)Cancer: 7 (7)ERP: 3, CC: 4IBD: 89 (86)ERP: 46, CC: 43Simple:(ERP: 47.1%, CC: 61.5)Multiple:(ERP: 29.4%, CC: 21.2)Open7 (5-11)9 (7-22)a0 (0)0 (0)11 (22)25 (48)a0 (0)0 (0)
Lee et al[13], 2011South KoreaRCT2007-2009100 (ERP: 46, CC: 54)Cancer: 100 (100)RH: 38 (ERP: 17, CC: 21)LH: 15 (ERP: 5, CC: 10)AR: 47 (ERP: 24, CC: 23)Lap7 (6-8)8 (7-9)0 (0)0 (0)6 (11)14 (20)0 (0)0 (0)
Vlug et al[9], 2011NetherlandsRCT200 -2009400 (ERP: 193, CC: 207)Cancer: 400 (100)RH: 179 (ERP: 80, CC: 99)LH: 221 (ERP: 120, CC: 101)Open/lapOpen: 7 (5-11)Lap: 5 (4-8)Open: 7 (6-13)Lap: 6 (4.5-9.5)a13 (7)14 (7)125 (65)132 (64)6 (3)4 (2)
Wang et al[26], 2012ChinaRCT2006-200978 (ERP: 40, CC: 38)Cancer: 78 (100)RH: 13 (ERP: 7, CC: 6)Sig: 34 (ERP: 18, CC:16)AR: 25 (ERP: 13, CC: 12)Lap5.5 (5-6)7.0 (6-8)aNDND2 (5)8 (21)0 (0)0 (0)
Table 2 Summary of previous studies that evaluated early rehabilitation programs after laparoscopic rectal surgery
Ref.CountryStudy designInclusion periodPatients (n)OperationsClinical effectiveness (LOS and complications)
Lindsetmo et al[22], 2009United StatesProspective cohort study2005-200737Cancer: 17 (46)Polyp: 4 (11)Others: 16 (43)SPS: 37 (100)Diverting ileostomy: 7 (19)Mean LOS: 3.0 d (range 1-8 d)Overall complications: 6 (16)UTI: 1; SSI: 2Readmission < 30 d: 3 (8)
Chen et al[27], 2011TaiwanProspective cohort study2007-200980Cancer: 76 (95)Benign: 4 (5)APR: 15 (19)SPS: 65 (81)Diverting ileostomy: 32 (49)Mean LOS: 5.0d (range 3-22)Overall complications: 11 (14)AL: 1; pelvic abscess 2; ileus: 1Readmission < 30 d: 7 (9)
Stottmeier et al[28], 2012DenmarkProspective cohort study2006-2009102Cancer: 102 (100)APR: 19 (19)Hartmann: 6 (6)SPS: 77 (75)Diverting colostomy: 38 (37)Diverting ileostomy: 3 (3)Median LOS: 5 d (range 2-42 d)Overall complications: 25 (25)AL: 3; intra-abdominal abscess: 3Readmission < 30 d: 15 (15)
Huibers et al[29], 2012Nether-landsRetrospective case-control study2004-200976 (ERP: 43, CC: 33)Cancer: 76 (100)APR: 24 (32)ERP: 16 (37)CC: 8 (24)SPS: 52 (68)ERP: 27 (63)CC: 25 (76)Median LOS: (P = 0.042)ERP: 7 d (range 2-83 d)CC: 10 d (range 4-74 d)Overall complications:ERP: 17 (40)AL: 5; intra-abdominal abscess: 7CC: 9 (27)AL: 4; intra-abdominal abscess: 3Readmission < 30 d: (P = 0.421)ERP: 5 (12)CC: 6 (18)
Lee et al[30], 2013South KoreaRCT2007-201198 (ERP: 52, CC: 46)Cancer 98 (100)SPS: 98 (100)Diverting ileostomy: 98 (100)Median recovery time1: (P = 0.47)ERP: 137 h (range 107-188 h)CC: 146.5 h (range 115-183 h)Overall complications: (P = 0.054)ERP: 22 (42)AL: 1; POI: 15; acute voiding difficulty: 9CC: 11 (24)AL: 1; POI: 6; acute voiding difficulty: 2Readmission < 30 d: 0 (0)
Table 3 Protocols used in previous studies for evaluating early rehabilitation programs after laparoscopic rectal surgery
ProtocolsLindsetmo et al[22], 2009Chen et al[27], 2011Stottmeier et al[28], 2012Huibers et al[29], 2012Lee et al[30], 2013
Preoperative stage
General considerationsPatient educationPatient education and ERP explanationThorough informationEstablishing a contractNDOperative risk assessmentCounseling, informed consent
Oral bowel preparationYesYesNo (enema for left-sided tumors)No (2 enemas)Yes
NPOND8 h before surgeryFluid until 2 h before surgery2 h before surgery8 h before surgery
Oral carbohydrate solutionNoNoNoYesNo
Epidural analgesiaNoNoYesYesNo
Prophylactic antibioticsNDSingle doseSingle dose (ampicillin + metronidazole + gentamicin)Single dose (cefalozine + metronidazole)ND
DVT prophylaxisNDNDLMWH 2 h before surgeryCompression stockingsLMWH until dischargeND
Perioperative stage
Operation approachLaparoscopicLaparoscopicLaparoscopicLaparoscopicLaparoscopic
AnesthesiaNDShort-acting anestheticsPropofol, remifentanyl and muscle relaxantNDND
FluidNDPerioperative fluid restrictionAvoid both hypovolemia and fluid overloadNDND
Urinary drainageUrethral catheterUrethral catheterSuprapubic or urethral catheterUrethral catheterUrethral catheter
Nasogastric tubeYes (orogastric tube, removed before extubation)NoNoNoNo
Intra-abdominal drainRarelyYesNoYes (one)Yes (one)
Postoperative stage
Pain controlIV PCA (12-18 h)KetorolacOral analgesiaOral NSAIDs immediatelyafter surgeryOpioid for 1 d if neededEpidural analgesiaParacetamol, ibuprofenOpioid if neededEpidural analgesiaParacetamol, diclofenacOpioid avoidedIV PCA till POD 2
Sipping waterImmediately after surgeryImmediately after surgeryImmediately after surgeryImmediately after surgeryImmediately after surgery
Oral food intakePOD 1POD 1Evening of the day of surgeryLiquid diet in the eveningSemi-fluid diet, POD 1
Removal of urinary catheterPOD 1POD 1Immediately after surgeryPOD 2POD 3
Removal of intra- abdominal drainNo drainPOD 4No drainPOD 2ND
MobilizationAs soon as possibleImmediately after surgeryTwo hours after surgeryPOD 1POD 1
Regular laxativesNDSennosideMgSO4 1 g two dimes dailyMgOMgO
Routine dischargeNDPOD 5POD 3NDND
Discharge criteriaTolerance of fluids and solid diet, adequate oral analgesia, passage of flatus or stool, adequate home supportNo fever, no tachycardia, successful passage of flatus/stool, tolerance for 3 meals/d, comfort in taking oral non-opioid analgesics, independent ambulation, adequate self-care abilityAdequate bladder and bowel function, ability to drink, eat, walk without problems, manageable painNo remaining lines or catheters, toleration of solid food, passage of stool, controllable pain, self-care abilityND (Recovery: tolerance of diet for 24 h, analgesic-free, safe ambulation, afebrile status without major complications)